Nephros hires Moshe Pinto to board
M2 - Tue Aug 18, 6:04AM CDT
Medical device company Nephros (OTCBB:NEPH) revealed on Monday that Moshe Pinto has been appointed to its board of directors.
Nephros, Inc. Enters Into Purchase Agreement with Lincoln Park Capital Fund, LLC
Business Wire - Mon Jul 27, 6:30AM CDT
Nephros, Inc. (OTCBB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration ("HDF"
SeeThruEquity Initiates Coverage on Nephros, Inc. (OTCBB: NEPH) with Price Target of $1.65
ACCESSWIRE - Thu Jun 04, 7:57AM CDT
NEW YORK, NY / ACCESSWIRE / June 4, 2015 / SeeThruEquity, a leading independent equity research and corporate access firm focused on smallcap and microcap public companies, today announced it has initiated coverage of Nephros, Inc. (OTCQB: NEPH) with Price Target of $1.65.
Nephros posts higher net operating loss of USD806,000 for Q1 2015
M2 - Mon May 18, 5:17AM CDT
Medical device company Nephros (OTCBB:NEPH) disclosed on Friday that it recorded a net operating loss of USD806,000 for the three months ended 31 March 2015.
Nephros expects USD1.2m from private placement of common shares
M2 - Wed May 13, 6:57AM CDT
Medical device company Nephros (OTCBB:NEPH) reported on Tuesday the launch of definitive agreements for the sale of about USD1.2m of its common stock.
Nephros hires Malcolm Persen to board
M2 - Mon May 11, 7:31AM CDT
Medical device company Nephros (OTCBB:NEPH) disclosed on Friday the addition appointment of Malcolm Persen to its board of directors, including chair of the Audit Committee.
Nephros signs HydraGuard military filter licensing agreement with CamelBak
M2 - Thu May 07, 5:15AM CDT
Medical device company Nephros (OTCBB:NEPH) reported on Wednesday that it has granted the exclusive license to its HydraGuard military filter to CamelBak for an undisclosed value.
New chief at Nephros
Seeking Alpha - at Seeking Alpha - Tue Apr 21, 6:32AM CDT
Nephros Announces Successful Completion of $3 Million Rights Offering
Business Wire - Thu Dec 18, 3:10PM CST
Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration system for use with a hemodialysis machine for the treatment of chronic renal failure patients, announced today the successful completion of its rights offering.
Nephros Provides Corporate Update
Business Wire - Mon Dec 08, 3:49PM CST
Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration system for use with a hemodialysis machine for the treatment of chronic renal failure patients, today provided an update on its operations and strategy.
Nephros Reports Third Quarter 2014 Financial Results and Announces Launch of Rights Offering
PR Newswire - Fri Nov 14, 3:05PM CST
Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration system for use with a hemodialysis machine for the treatment of chronic renal failure patients, announced today financial results for the three and nine months ended September 30, 2014 and the launch of its previously announced rights offering.
Nephros Receives 510(k) Clearance for DSU-H and SSU-H Ultrafilters
PR Newswire - Tue Oct 28, 3:05PM CDT
Nephros, Inc. (OTCQB: NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration system for use with a hemodialysis machine for the treatment of chronic renal failure patients, today announced that the Company has received 510(k) clearance from the Food and Drug Administration ("FDA"